<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: It remains to be investigated whether smoking is associated with colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> through specific epigenetic or genetic alterations, or abnormal protein expression </plain></SENT>
<SENT sid="1" pm="."><plain>We comprehensively examined the influence of smoking on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk by specific <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> molecular features, including epigenetic status (CpG island methylator phenotype [CIMP]), genomic instability (microsatellite instability [MSI]), oncogenic mutations (BRAF, KRAS, and PIK3CA), and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> protein expressions (DNA methyltransferase-3B [DNMT3B], TP53, PTGS2 [cyclooxygenase-2], FASN, and CTNNB1 [b-catenin]) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Follow-up of 134,204 individuals in two U.S. nationwide prospective cohorts (Nurses' Health Study [1980-2008] and Health Professionals Follow-up Study [1986-2008]) resulted in 1,292 incident rectal and <z:hpo ids='HP_0003003'>colon cancers</z:hpo> with available molecular data </plain></SENT>
<SENT sid="3" pm="."><plain>Duplication method Cox proportional hazards model was used to calculate multivariate hazard ratio (HR) for developing a specific subtype of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> according to smoking status </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared with never smokers, smoking of â‰¥40 cumulative pack-years was associated with increased risks for specific molecular types of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Multivariate HRs are 2.12 for CIMP-high <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% confidence interval [CI], 1.48- 3.03), 2.27 for MSI-high <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.56-3.31), 2.00 for BRAF-mutated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.37-2.92), 1.37 for KRAS-<z:mp ids='MP_0002169'>wild-type</z:mp> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.12-1.68), 1.30 for PIK3CA-<z:mp ids='MP_0002169'>wild-type</z:mp> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.07-1.58), 1.33 for TP53-negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.05-1.69), 1.37 for PTGS2-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.09-1.73), 1.36 for FASN-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.07-1.73), and 1.35 for CTNNB1-negative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% CI, 1.04-1.74) </plain></SENT>
<SENT sid="6" pm="."><plain>The influence of smoking significantly differed according to status of CIMP (P = 0.001 for <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> test of CIMP-low vs. CIMP-high) and MSI (P = 0.0003 for <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> test of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> vs. MSI-high) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no statistically significant differential association of smoking with other molecular subtypes </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: This molecular pathological epidemiology (MPE) study suggests that smoking might primarily cause epigenetic alterations, which lead to oncogenic mutations in colonic cells </plain></SENT>
</text></document>